Impact of definitions of loss to follow-up (LTFU) in antiretroviral therapy program evaluation: variation in the definition can have an appreciable impact on estimated proportions of LTFU.

[1]  F. Behets,et al.  Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting , 2013, AIDS.

[2]  E. Mills,et al.  Preventing Antiretroviral Treatment Interruptions among HIV/AIDS Patients in Africa , 2013, PLoS medicine.

[3]  Kara Wools-Kaloustian,et al.  Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa. , 2012, International journal of epidemiology.

[4]  B. Chi,et al.  Estimating Loss to Follow-Up in HIV-Infected Patients on Antiretroviral Therapy: The Effect of the Competing Risk of Death in Zambia and Switzerland , 2011, PloS one.

[5]  B. Chi,et al.  Universal Definition of Loss to Follow-Up in HIV Treatment Programs: A Statistical Analysis of 111 Facilities in Africa, Asia, and Latin America , 2011, PLoS medicine.

[6]  N. Ford,et al.  Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review , 2011, Tropical medicine & international health : TM & IH.

[7]  N. Ford,et al.  Defaulting from antiretroviral treatment programmes in sub‐Saharan Africa: a problem of definition , 2011, Tropical medicine & international health : TM & IH.

[8]  N. Ford,et al.  Correcting for Mortality Among Patients Lost to Follow Up on Antiretroviral Therapy in South Africa: A Cohort Analysis , 2011, PloS one.

[9]  P. Kaleebu,et al.  An appraisal of indicators used to monitor the treated population in antiretroviral programmes in low-income countries , 2010, AIDS.

[10]  N. Ford,et al.  Treatment Interruption in a Primary Care Antiretroviral Therapy Program in South Africa: Cohort Analysis of Trends and Risk Factors , 2010, Journal of acquired immune deficiency syndromes.

[11]  L. Myer,et al.  Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007 , 2010, AIDS.

[12]  J. Sterne,et al.  Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes , 2010, The Lancet.

[13]  S. Rosen,et al.  Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: systematic review , 2010, Tropical medicine & international health : TM & IH.

[14]  I. Sanne,et al.  Using vital registration data to update mortality among patients lost to follow‐up from ART programmes: evidence from the Themba Lethu Clinic, South Africa , 2010, Tropical medicine & international health : TM & IH.

[15]  B. Chi,et al.  American Journal of Epidemiology Practice of Epidemiology an Empirical Approach to Defining Loss to Follow-up among Patients Enrolled in Antiretroviral Treatment Programs , 2022 .

[16]  N. Ford,et al.  Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa , 2010, AIDS.

[17]  M. Egger,et al.  Mortality after failure of antiretroviral therapy in sub‐Saharan Africa , 2010, Tropical medicine & international health : TM & IH.

[18]  B. Eley,et al.  Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration. , 2009, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[19]  M. Egger,et al.  Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource-Limited Settings: Systematic Review and Meta-Analysis , 2009, PloS one.

[20]  P. Pronyk,et al.  Mortality and loss to follow-up among HAART initiators in rural South Africa. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[21]  D. Chadwick,et al.  Sustained immunological responses to highly active antiretroviral therapy at 36 months in a Ghanaian HIV cohort. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  S. Cha,et al.  Youth, unemployment, and male gender predict mortality in AIDS patients started on HAART in Nigeria , 2009, AIDS care.

[23]  A. De Luca,et al.  Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral- treated patients in sub-Saharan African Sites with comprehensive monitoring availability. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  V. DeGruttola,et al.  Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program , 2008, AIDS.

[25]  L. Myer,et al.  Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. , 2008, Bulletin of the World Health Organization.

[26]  F. Dabis,et al.  Rapid scaling-up of antiretroviral therapy in 10 000 adults in Côte d'Ivoire: 2-year outcomes and determinants , 2008, AIDS.

[27]  L. Sandvik,et al.  Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania , 2008, BMC infectious diseases.

[28]  L. Palombi,et al.  Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings. , 2008, AIDS research and human retroviruses.

[29]  R. Gross,et al.  Overestimates of Survival after HAART: Implications for Global Scale-Up Efforts , 2008, PLoS ONE.

[30]  D. Masys,et al.  Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. , 2007, International journal of epidemiology.

[31]  Sydney Rosen,et al.  Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review , 2007, PLoS medicine.

[32]  Richard D Moore,et al.  Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). , 2007, International journal of epidemiology.

[33]  S. Lawn,et al.  Conservation of First-Line Antiretroviral Treatment Regimen where Therapeutic Options are Limited , 2007, Antiviral therapy.

[34]  Adeeba Kamarulzaman,et al.  AIDS Res Hum Retroviruses , 2006 .

[35]  J. Sterne,et al.  Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries , 2006, The Lancet.

[36]  N. Michael,et al.  Joint United Nations Programme on HIV/AIDS. , 2004, Military medicine.

[37]  S. De Geest,et al.  Adherence to Long-Term Therapies: Evidence for Action , 2003, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[38]  Norman E. Breslow,et al.  The design and analysis of cohort studies , 1987 .

[39]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.

[40]  Sander Greenland,et al.  Modern Epidemiology 3rd edition , 1986 .